Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Wockhardt Ltd

WOCKPHARMA.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Mid Cap Analyst: N/A

Last Close

$20.25

▲ +1.04%

Market Cap $3.29B · Vol 480.22K

Key Metrics

P/E Ratio

76.78

FWD: N/A

Market Cap

$3.29B

Mid Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

56.18

Momentum

Beta

1.55

vs Market

52W High

$25.38

20.59% below

52W Low

$11.39

73.66% above

Volume

480.22K

Avg 669.65K

P/B

3.87

Price-to-book

ROE

N/A

Return on equity

Free Float

48.98%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Wockhardt Ltd (WOCKPHARMA.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does WOCKPHARMA.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-4.37%

+4.43%

+24.92%

+38.56%

YTD

+33.64%

+26.73%

+593.10%

+309.41%

Financials & Valuation

TTM · Annual

Total Revenue	$360.91M
Net Income	$21.29M
Revenue Growth (YoY)	+25.88%
Gross Margin	56.42%
Operating Margin	11.95%
Net Profit Margin	5.90%
ROE	N/A
ROA · ROIC	2.84% · 5.45%

P/E Ratio	76.78
Forward P/E (FY1)	N/A
PEG Ratio	0.17
P/S	5.67
P/B	3.87
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	162.49M

Technical Indicators

50-Day SMA	$20.13
200-Day SMA	$16.07
RSI (14)	56.18
Beta	1.55
52-Week High	$25.38
52-Week Low	$11.39

Volume Today	480.22K
Avg Daily Volume (30D)	669.65K
Relative Volume	0.72x
Volatility (10D)	40.69
Volatility (30D)	30.93
Free Float	48.98%

Analyst Consensus

N/A

Current Price $20.25

Mean Target N/A

52W Low$11.39 52W High$25.38

Current

Target

$11.39 $25.38

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001SDN510

ISININE049B01025

CountryIndia

Sub-IndustryGeneric Pharmaceuticals

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

SUNPHARMA.NS Sun Pharmaceutical Industries Ltd -0.10% 4578.T Otsuka Holdings Co Ltd -3.26% CIPLA.NS Cipla Ltd -0.60% ZYDUSLIFE.NS Zydus Lifesciences Ltd -2.75% RICHTER.BU Richter Gedeon Vegyeszeti Gyar Nyrt +1.56%

Company Profile

Wockhardt Limited is a research-based global pharmaceutical and biotech company. The Company is engaged in the pharmaceutical business. It focuses on the unmet need for antibacterial drugs that are effective against the menace of untreatable superbugs. It manufactures and supplies branded and generic finished formulations, as well as intermediate products like active pharmaceutical ingredients (APIs), worldwide. The Company’s products in India include EMROK, MERIWOK, REINVEXIN, ERLISO, METHYCOBAL 500 MCG 15T, METHYCOBAL INJ 1 ML, METHYCOBAL D 10T, HAPID 10C, PROXYFEN NANO GEL, LIVATIRA 500 10T NEW PACK, LIVATIRA INJ 5 ml, GABAWOK NT 100MG 15T, GABAWOK NT 400MG 15T, ETOBRIX 90 MG 10C, ETOBRIX TH 4 10C, ETOBRIX P 10T, GLARZEN 100IU, TERITIDE, GLIMADAY HS, GLIMADAY FORTE-2, GLIMADAY FORTE-1, GLIMADAY FORTE 3, GLIMADAY 2 mg, GLIMADAY 1 mg, MOPADAY FORTE, INOGLA, WEPOX 4000 IU 1ML, MYCORAL M, Val 450, OKERON INJ 100MCG 1ML, DARBOTIN 40, and DARBOTIN 60.